摘要: Children can expect the medicines prescribed for them to have at least as good an evidence base in adult practice. Current licensing arrangements UK ensure a rigorous assessment of most drugs used adults, whereas prescribing outside licence is relatively common children. Until increased, consensus guidelines or formularies, such new British National Formulary Children, provide some protection children and prescribers. For future, there optimism that dearth research on which children’s will be addressed by initiatives, Medicines Research Network draft EU legislation providing incentives industry.